查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1833579

2032 年整形外科植入市場預測：按產品類型、生物材料、手術程序、設備類型、最終用戶和地區進行的全球分析

Orthopedic Implants Market Forecasts to 2032 - Global Analysis By Product Type, Biomaterial, Procedure, Device Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球整形外科植入市場預計在 2025 年達到 559.2 億美元，到 2032 年將達到 863.3 億美元，預測期內的複合年成長率為 6.4%。

整形外科植入是醫療設備，旨在透過替換、穩定或加強受損的骨骼結構來幫助修復骨骼和關節。這些植入通常由耐用且生物相容性的材料製成，例如鈦、不銹鋼或陶瓷，可安全用於人體。它們常用於整形外科手術，以治療骨折、關節炎和退化性骨病。透過恢復結構完整性和運動功能，它們可以顯著減輕不適，並增強患者的功能健康和幸福感。

根據世界衛生組織 (WHO) 2022 年的數據，全球有 17.1 億人患有肌肉骨骼疾病，包括背痛、頸部、骨折、其他損傷、骨關節炎、類風濕性關節炎和類風濕性關節炎。

老年人口不斷增加

骨質疏鬆症、關節炎和關節退化等疾病在老年人中日益普遍，需要手術介入。醫療保健系統擴大採用先進的植入技術，以改善老年患者的活動能力和生活品質。微創整形外科手術日益普及，縮短了復原時間和住院時間。植入設計和生物材料的創新正在改善植入物的貼合度和長期療效。隨著全球預期壽命的延長，整形外科植入市場可望持續擴張。

熟練骨科醫生短缺

訓練有素的骨科醫生短缺阻礙了整形外科植入領域的發展。許多地區，尤其是新興國家，在專業外科手術方面面臨巨大的人才缺口。植入手術的複雜性需要嚴格的訓練和經驗積累，導致合格人員數量有限。監管要求和認證流程進一步阻礙了新外科醫生進入該領域。這種人才缺口導致手術延誤和患者預後不佳。如果不對醫學教育和培訓進行策略性投資，市場成長可能會受到限制。

門診手術中心（ASC）的興起

日間手術中心正成為整形外科植入市場的成長引擎。這些設施為在傳統醫院外進行整形外科手術提供了經濟高效的環境。日間手術中心配備的先進影像處理和手術技術日益增多，能夠加快複雜植入手術的患者周轉速度。優惠的報銷政策和更短的恢復時間正吸引患者和醫療服務提供者來到這些中心。門診病人護理的趨勢正在加速對攜帶式模組化植入系統的需求。隨著醫療保健的去中心化，日間手術中心正成為整形外科創新和服務交付的重要樞紐。

定價壓力和報銷問題

政府和保險公司正在加強成本控制，迫使製造商降低價格。報銷延遲和政策變化擾亂了現金流，阻礙了產品的普及。高昂的開發和合規成本使得公司難以在這種環境下保持盈利。規模較小的公司尤其容易受到價格波動和報銷不確定性。這些財務壓力可能會減緩創新，並限制先進植入技術的普及。

COVID-19的影響：

新冠疫情擾亂了整形外科植入手術，推遲了擇期手術，並導致醫院資源緊張。封鎖和供應鏈中斷導致植入零件和手術器械短缺。然而，這場危機加速了數位化應用，遠距會診和遠距復健變得越來越流行。監管機構推出了快速核准，以確保患者能夠持續獲得必要的整形外科設備。疫情後的策略如今強調韌性、自動化和本地製造，以減輕未來的干擾。市場正在適應變化，重新整體整形外科護理的靈活性和數位化整合。

金屬生物材料領域預計將成為預測期內最大的領域

預計金屬生物材料領域將在預測期內佔據最大的市場佔有率。這些材料，包括鈦和不銹鋼，在承重應用中具有卓越的強度、生物相容性和耐久性。它們在人工關節、脊椎移植和創傷固定裝置中的廣泛應用，推動了其市場主導。表面塗層和合金成分的不斷進步，正在改善其與骨組織的整合。醫院和外科中心因其可靠性和長期性能而更青睞金屬植入。隨著整形外科手術需求的不斷成長，金屬生物材料很可能將繼續在植入創新中發揮關鍵作用。

預計門診手術中心部分在預測期內的複合年成長率最高

預計門診手術中心細分市場將在預測期內達到最高成長率。門診手術中心 (ASC) 能夠以低成本提供優質護理，正在重塑外科手術格局。 ASC 擴大使用先進的植入系統進行關節重建和骨折修復。營運效率的提高和良好的保險覆蓋範圍正在推動患者對這些設施的偏好。數位庫存和雲端基礎監控的整合正在簡化植入管理。隨著門診整形外科護理的擴展，ASC 可能在加速市場發展方面發揮關鍵作用。

比最大的地區

預計亞太地區將在預測期內佔據最大的市場佔有率。快速的都市化和醫療基礎設施的擴張正在推動該地區手術數量的成長。中國、印度和日本等國正在投資整形外科器械的國內生產和技術進步。政府正在主導促進自給自足，減少對進口的依賴。機器人輔助手術和人工智慧診斷在領先醫院的應用正在蓬勃發展。全球和本地公司之間的策略合作夥伴關係正在推動市場滲透和技術創新。

複合年成長率最高的地區：

預計北美將在預測期內實現最高的複合年成長率。該地區在手術機器人、智慧手術室和人工智慧整形外科診斷領域處於領先地位。監管機構正在簡化下一代植入的核准途徑，加速其商業化進程。醫院正在利用數據分析和物聯網來最佳化手術工作流程和植入的使用率。強大的報銷框架和微創技術的廣泛應用支撐著市場擴張。在精準醫療的推動下，北美持續引領整形外科創新的標竿。

免費客製化服務：

此報告的訂閱者可以選擇以下免費自訂選項之一：

  • 公司簡介
    • 對最多三家其他市場公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

第5章全球整形外科植入市場（依產品類型）

  • 重組關節重建
    • 髖關節植入
    • 肩關節關節移植
    • 膝關節植入
  • 脊椎移植
    • 核融合裝置
    • 非融合裝置
  • 人工植牙
  • 創傷植入
  • 生物性骨材
  • 顱顎顏面植入
  • 其他產品類型

6. 全球整形外科植入市場（依生物材料）

  • 金屬生物材料
  • 陶瓷生物材料
  • 天然生物材料
  • 聚合物生物材料

7. 全球整形外科植入市場（依手術類型）

  • 開放性手術
  • 機器人輔助手術
  • 微創手術（MIS）

8. 全球整形外科植入市場（依設備類型）

  • 內固定裝置
    • 盤子
    • 指甲
    • 擰緊
  • 外固定裝置
    • 框架
    • 別針

9. 全球整形外科植入市場（依最終用戶）

  • 醫院
  • 居家照護環境
  • 整形外科診所
  • 門診手術中心
  • 其他最終用戶

第 10 章全球整形外科植入市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Stryker Corporation
  • Orthofix Medical Inc.
  • Zimmer Biomet Holdings, Inc.
  • Wright Medical Group NV
  • Smith & Nephew plc
  • BioTek Instruments
  • Johnson & Johnson
  • Exactech, Inc.
  • Medtronic plc
  • B. Braun Melsungen AG
  • Arthrex, Inc.
  • Globus Medical, Inc.
  • CONMED Corporation
  • DJO Global
  • NuVasive, Inc.
Product Code: SMRC31412

According to Stratistics MRC, the Global Orthopedic Implants Market is accounted for $55.92 billion in 2025 and is expected to reach $86.33 billion by 2032 growing at a CAGR of 6.4% during the forecast period. Orthopedic implants are medical devices designed to aid in bone and joint repair by replacing, stabilizing, or reinforcing injured skeletal structures. Typically manufactured from durable, biocompatible materials like titanium, stainless steel, or ceramics, these implants ensure safety within the human body. They are frequently applied in orthopedic surgeries to address fractures, arthritis, or degenerative bone problems. By restoring structural integrity and movement, they significantly alleviate discomfort and enhance the patient's functional health and well-being.

According to data by the World Health Organization (WHO) 2022, 1.71 billion people have musculoskeletal conditions, including low back pain, neck pain, fractures, other injuries, osteoarthritis, amputation, and rheumatoid arthritis.

Market Dynamics:

Driver:

Increasing geriatric population

Conditions such as osteoporosis, arthritis, and joint degeneration are becoming more prevalent among seniors, necessitating surgical interventions. Healthcare systems are increasingly adopting advanced implant technologies to improve mobility and quality of life for aging patients. Minimally invasive orthopedic procedures are gaining traction, reducing recovery time and hospital stays. Innovations in implant design and biomaterials are enhancing compatibility and long-term outcomes. As life expectancy rises globally, the orthopedic implants market is poised for sustained expansion.

Restraint:

Dearth of skilled orthopedic surgeons

A shortage of trained orthopedic surgeons is hindering the growth of the orthopedic implants sector. Many regions, especially in developing countries, face a critical gap in specialized surgical expertise. The complexity of implant procedures demands rigorous training and experience, which limits the number of qualified professionals. Regulatory requirements and certification processes further slow the entry of new surgeons into the field. This talent gap can lead to delayed surgeries and suboptimal patient outcomes. Without strategic investment in medical education and training, market growth may be constrained.

Opportunity:

Rise of ambulatory surgical centers (ASCs)

Ambulatory surgical centers are emerging as key drivers of growth in the orthopedic implants market. These facilities offer cost-effective, high-efficiency environments for performing orthopedic procedures outside traditional hospitals. ASCs are increasingly equipped with advanced imaging and surgical technologies, enabling complex implant surgeries with faster patient turnover. Favorable reimbursement policies and shorter recovery times are attracting both patients and providers to these centers. The trend toward outpatient care is accelerating demand for portable and modular implant systems. As healthcare decentralizes, ASCs are becoming vital hubs for orthopedic innovation and service delivery.

Threat:

Pricing pressures and reimbursement issues

Governments and insurers are tightening cost controls, putting pressure on manufacturers to reduce prices. Reimbursement delays and policy shifts can disrupt cash flow and hinder product adoption. High development and compliance costs make it difficult for companies to maintain profitability under these conditions. Smaller firms are particularly vulnerable to pricing volatility and reimbursement uncertainty. These financial pressures may slow innovation and limit access to advanced implant technologies.

Covid-19 Impact:

The COVID-19 pandemic disrupted orthopedic implant procedures by postponing elective surgeries and straining hospital resources. Lockdowns and supply chain interruptions led to shortages in implant components and surgical tools. However, the crisis accelerated digital adoption, with remote consultations and tele-rehabilitation gaining popularity. Regulatory bodies introduced fast-track approvals to ensure continued access to essential orthopedic devices. Post-pandemic strategies now emphasize resilience, automation, and localized manufacturing to mitigate future disruptions. The market is adapting with renewed focus on flexibility and digital integration across the orthopedic care continuum.

The metallic biomaterialssegment is expected to be the largest during the forecast period

The metallic biomaterials segment is expected to account for the largest market share during the forecast period. These materials, including titanium and stainless steel, offer superior strength, biocompatibility, and durability for load-bearing applications. Their widespread use in joint replacements, spinal implants, and trauma fixation devices underpins their market leadership. Continuous advancements in surface coatings and alloy compositions are improving integration with bone tissue. Hospitals and surgical centers prefer metallic implants for their reliability and long-term performance. As demand for orthopedic procedures rises, metallic biomaterials will remain the cornerstone of implant innovation.

The ambulatory surgical centerssegment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ambulatory surgical centerssegment is predicted to witness the highest growth rate. Their ability to deliver high-quality care at lower costs is reshaping the surgical landscape. ASCs are increasingly performing joint replacements and fracture repairs using advanced implant systems. Enhanced operational efficiency and favorable insurance coverage are driving patient preference for these facilities. Integration of digital inventory and cloud-based monitoring is streamlining implant management. As outpatient orthopedic care expands, ASCs will play a pivotal role in market acceleration.

Region with largest share:

During the forecast period, the Asia Pacificregion is expected to hold the largest market share. Rapid urbanization and expanding healthcare infrastructure are fueling surgical volumes across the region. Countries like China, India, and Japan are investing in domestic production and technological upgrades for orthopedic devices. Government initiatives are promoting self-sufficiency and reducing reliance on imports. Adoption of robotic-assisted surgeries and AI diagnostics is gaining momentum in major hospitals. Strategic collaborations between global and local players are enhancing market penetration and innovation.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR. The region leads in surgical robotics, smart operating rooms, and AI-powered diagnostics for orthopedic care. Regulatory agencies are streamlining approval pathways for next-generation implants, accelerating commercialization. Hospitals are leveraging data analytics and IoT to optimize surgical workflows and implant utilization. Strong reimbursement frameworks and high adoption of minimally invasive techniques are supporting market expansion. As precision medicine advances, North America continues to set the benchmark for orthopedic innovation.

Key players in the market

Some of the key players in Orthopedic Implants Market include Stryker Corporation, Orthofix Medical Inc., Zimmer Biomet Holdings, Inc., Wright Medical Group N.V., Smith & Nephew plc, BioTek Instruments, Johnson & Johnson, Exactech, Inc., Medtronic plc, B. Braun Melsungen AG, Arthrex, Inc., Globus Medical, Inc., CONMED Corporation, DJO Global, and NuVasive, Inc.

Key Developments:

In June 2025, Orthofix Medical Inc. announced the global commercial launch of the TrueLok(TM) Elevate Transverse Bone Transport (TBT) System. TrueLok Elevate represents the first commercially available device in the U.S. with a patented design for use in the TBT procedure to provide a limb preservation treatment option for addressing bony or soft tissue deformities or defects, such as diabetic ulcers.

In February 2025, Stryker announced that it has completed the acquisition of Inari Medical, Inc., a company that provides innovative solutions for venous thromboembolism (VTE) clot removal without the use of thrombolytic drugs. The addition of Inari brings an established peripheral vascular position to Stryker in the fast-growing VTE segment.

Product Types Covered:

  • Reconstructive Joint Replacements
  • Spinal Implants
  • Dental Implants
  • Trauma Implants
  • Orthobiologics
  • Craniomaxillofacial Implants
  • Other Product Types

Biomaterials Covered:

  • Metallic Biomaterials
  • Ceramic Biomaterials
  • Natural Biomaterials
  • Polymeric Biomaterials

Procedures Covered:

  • Open Surgery
  • Robotic-Assisted Surgery
  • Minimally Invasive Surgery (MIS)

Device Types Covered:

  • Internal Fixation Devices
  • External Fixation Devices

End Users Covered:

  • Hospitals
  • Home Care Settings
  • Orthopedic Clinics
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.90 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Orthopedic Implants Market, By Product Type

  • 5.1 Introduction
  • 5.2 Reconstructive Joint Replacements
    • 5.2.1 Hip Implants
    • 5.2.2 Shoulder Implants
    • 5.2.3 Knee Implants
  • 5.3 Spinal Implants
    • 5.3.1 Fusion Devices
    • 5.3.2 Non-fusion Devices
  • 5.4 Dental Implants
  • 5.5 Trauma Implants
  • 5.6 Orthobiologics
  • 5.7 Craniomaxillofacial Implants
  • 5.8 Other Product Types

6 Global Orthopedic Implants Market, By Biomaterial

  • 6.1 Introduction
  • 6.2 Metallic Biomaterials
  • 6.3 Ceramic Biomaterials
  • 6.4 Natural Biomaterials
  • 6.5 Polymeric Biomaterials

7 Global Orthopedic Implants Market, By Procedure

  • 7.1 Introduction
  • 7.2 Open Surgery
  • 7.3 Robotic-Assisted Surgery
  • 7.4 Minimally Invasive Surgery (MIS)

8 Global Orthopedic Implants Market, By Device Type

  • 8.1 Introduction
  • 8.2 Internal Fixation Devices
    • 8.2.1 Plates
    • 8.2.2 Nails
    • 8.2.3 Screws
  • 8.3 External Fixation Devices
    • 8.3.1 Frames
    • 8.3.2 Pins

9 Global Orthopedic Implants Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Home Care Settings
  • 9.4 Orthopedic Clinics
  • 9.5 Ambulatory Surgical Centers
  • 9.6 Other End Users

10 Global Orthopedic Implants Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Stryker Corporation
  • 12.2 Orthofix Medical Inc.
  • 12.3 Zimmer Biomet Holdings, Inc.
  • 12.4 Wright Medical Group N.V.
  • 12.5 Smith & Nephew plc
  • 12.6 BioTek Instruments
  • 12.7 Johnson & Johnson
  • 12.8 Exactech, Inc.
  • 12.9 Medtronic plc
  • 12.10 B. Braun Melsungen AG
  • 12.11 Arthrex, Inc.
  • 12.12 Globus Medical, Inc.
  • 12.13 CONMED Corporation
  • 12.14 DJO Global
  • 12.15 NuVasive, Inc.

List of Tables

  • Table 1 Global Orthopedic Implants Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Orthopedic Implants Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Orthopedic Implants Market Outlook, By Reconstructive Joint Replacements (2024-2032) ($MN)
  • Table 4 Global Orthopedic Implants Market Outlook, By Hip Implants (2024-2032) ($MN)
  • Table 5 Global Orthopedic Implants Market Outlook, By Shoulder Implants (2024-2032) ($MN)
  • Table 6 Global Orthopedic Implants Market Outlook, By Knee Implants (2024-2032) ($MN)
  • Table 7 Global Orthopedic Implants Market Outlook, By Spinal Implants (2024-2032) ($MN)
  • Table 8 Global Orthopedic Implants Market Outlook, By Fusion Devices (2024-2032) ($MN)
  • Table 9 Global Orthopedic Implants Market Outlook, By Non-fusion Devices (2024-2032) ($MN)
  • Table 10 Global Orthopedic Implants Market Outlook, By Dental Implants (2024-2032) ($MN)
  • Table 11 Global Orthopedic Implants Market Outlook, By Trauma Implants (2024-2032) ($MN)
  • Table 12 Global Orthopedic Implants Market Outlook, By Orthobiologics (2024-2032) ($MN)
  • Table 13 Global Orthopedic Implants Market Outlook, By Craniomaxillofacial Implants (2024-2032) ($MN)
  • Table 14 Global Orthopedic Implants Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 15 Global Orthopedic Implants Market Outlook, By Biomaterial (2024-2032) ($MN)
  • Table 16 Global Orthopedic Implants Market Outlook, By Metallic Biomaterials (2024-2032) ($MN)
  • Table 17 Global Orthopedic Implants Market Outlook, By Ceramic Biomaterials (2024-2032) ($MN)
  • Table 18 Global Orthopedic Implants Market Outlook, By Natural Biomaterials (2024-2032) ($MN)
  • Table 19 Global Orthopedic Implants Market Outlook, By Polymeric Biomaterials (2024-2032) ($MN)
  • Table 20 Global Orthopedic Implants Market Outlook, By Procedure (2024-2032) ($MN)
  • Table 21 Global Orthopedic Implants Market Outlook, By Open Surgery (2024-2032) ($MN)
  • Table 22 Global Orthopedic Implants Market Outlook, By Robotic-Assisted Surgery (2024-2032) ($MN)
  • Table 23 Global Orthopedic Implants Market Outlook, By Minimally Invasive Surgery (MIS) (2024-2032) ($MN)
  • Table 24 Global Orthopedic Implants Market Outlook, By Device Type (2024-2032) ($MN)
  • Table 25 Global Orthopedic Implants Market Outlook, By Internal Fixation Devices (2024-2032) ($MN)
  • Table 26 Global Orthopedic Implants Market Outlook, By Plates (2024-2032) ($MN)
  • Table 27 Global Orthopedic Implants Market Outlook, By Nails (2024-2032) ($MN)
  • Table 28 Global Orthopedic Implants Market Outlook, By Screws (2024-2032) ($MN)
  • Table 29 Global Orthopedic Implants Market Outlook, By External Fixation Devices (2024-2032) ($MN)
  • Table 30 Global Orthopedic Implants Market Outlook, By Frames (2024-2032) ($MN)
  • Table 31 Global Orthopedic Implants Market Outlook, By Pins (2024-2032) ($MN)
  • Table 32 Global Orthopedic Implants Market Outlook, By End User (2024-2032) ($MN)
  • Table 33 Global Orthopedic Implants Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 34 Global Orthopedic Implants Market Outlook, By Home Care Settings (2024-2032) ($MN)
  • Table 35 Global Orthopedic Implants Market Outlook, By Orthopedic Clinics (2024-2032) ($MN)
  • Table 36 Global Orthopedic Implants Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 37 Global Orthopedic Implants Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.